Publications by authors named "Kylee MacLachlan"

Claim this Profile
G
Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemia.
Tina Bagratuni, Ourania Theologi, Christos Vlachos, Ioannis Kollias, Kylee Maclachlan

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders - Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model.
Urvi A Shah, Laura Lucia Cogrossi, Juan-Jose Garces, Anna Policastro, Francesca Castro, Kylee H Maclachlan

Cancer Discov· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis and patterns of progression in smoldering multiple myeloma.
Theresia Akhlaghi, Kylee H Maclachlan, Adriana Wiggins, Saad Z Usmani, Andriy Derkach

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myeloma.
Francesco Maura, Ciara L Freeman, Kylee H Maclachlan, Marta Larrayoz Ilundain, Bachisio Ziccheddu

bioRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune MRD Status Informs Tumor MRD Outcome Prognostication in Patients with Multiple Myeloma on Lenalidomide Maintenance.
Ross S Firestone, Anish K Simhal, Devin McAvoy, Eric M Jurgens, Juan-Jose Garcés, Kylee H Maclachlan

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma.
Eric Jurgens, Tala Shekarkhand, Colin Rueda, David Nemirovsky, Andriy Derkach, Kylee Maclachlan

Blood Cancer J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomics Define Malignant Transformation in Myeloma Precursor Conditions.
Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, Shaji Kumar, Kylee Maclachlan

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma.
Tara Sebastian, Sridevi Rajeeve, Tasmin Farzana, Ross Firestone, Eric Jurgens, Kylee Maclachlan

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust CD4 CAR T cell Expansion Is Associated with Non-ICANS Neurotoxicities Following Ciltacabtagene Autoleucel.
Eric M Jurgens, Sneha Mitra, Kevin Herrera, David Nemirovsky, Brenden Bready, Kylee Maclachlan

medRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.
Benjamin Diamond, Dhanvantri Chahar, Michael D Jain, Alexandra M Poos, Michael A Durante, Kylee H Maclachlan

Blood Cancer Discov· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal genomic dynamics shape clinical trajectory in multiple myeloma.
Francesco Maura, Marcella Kaddoura, Alexandra M Poos, Linda B Baughn, Bachisio Ziccheddu, Kylee Maclachlan

Nat Genet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the Rates of Cytokine Release Syndrome Associated With Talquetamab Step-up Doses.
Issam S Hamadeh, Lisa Modelevsky, Amelia Chan, Aaron Mitchell, Ross S Firestone, Kylee Maclachlan

JCO Oncol Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma.
Juan-Jose Garces, Benjamin Diamond, Tereza Sevcikova, Serafim Nenarokov, Daniel Bilek, Kylee Maclachlan

Hemasphere· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma.
Benjamin Adegbite, Carlyn Rose Tan, Tala Shekarkhand, Ross S Firestone, Eric M Jurgens, Kylee H Maclachlan

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience.
Malin Hultcrantz, Andriy Derkach, Hani Hassoun, Neha Korde, Kylee Maclachlan

Blood Neoplasia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma.
Tara Sebastian, Sridevi Rajeeve, Tasmin Farzana, Ross Firestone, Eric Jurgens, Kylee Maclachlan

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restarting teclistamab and talquetamab after prolonged dose delay may not require re-step-up dosing.
Carlyn Rose Tan, Alice Wang, David Nemirovsky, Andriy Derkach, Tala Shekarkhand, Kylee Maclachlan

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AncestryGeni: a novel genetic ancestry classification pipeline for small and noisy sequence data.
Eran Elhaik, Sara Behnamian, Michael Howe, Hongwei Tang, Huihuang Yan, Kylee MacLachlan

Bioinformatics· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating serum free light chain ratio as a biomarker in multiple myeloma.
Theresia Akhlaghi, Kylee Maclachlan, Neha Korde, Sham Mailankody, Alexander Lesokhin

Haematologica· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High WEE1 expression is independently linked to poor survival in multiple myeloma.
Anish K Simhal, Ross S Firestone, Jung Hun Oh, Viswatej Avutu, Larry Norton, Kylee H Maclachlan

Blood Cancer J· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies.
Benjamin Diamond, Dhanvantri Chahar, Michael D Jain, Alexandra M Poos, Michael Durante, Kylee Maclachlan

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma.
Francesco Maura, Marcella Kaddoura, Alexandra M Poos, Linda B Baughn, Bachisio Ziccheddu, Kylee Maclachlan

bioRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma.
Malin Hultcrantz, Hani Hassoun, Neha Korde, Kylee MacLachlan, Sham Mailankody

Blood Cancer J· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High WEE1 expression is independently linked to poor survival in multiple myeloma.
Anish K Simhal, Ross Firestone, Jung Hun Oh, Viswatej Avutu, Larry Norton, Kylee H Maclachlan

bioRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colesevelam for Lenalidomide Associated Diarrhea in Patients with Multiple Myeloma.
Malin Hultcrantz, Hani Hassoun, Neha Korde, Kylee Maclachlan, Sham Mailankody

Res Sq· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis